Last reviewed · How we verify

NCT06707077

The Effect of Sevoflurane on Haemodynamics

Completed Last updated 12 March 2025
What this trial tests

trial in Sevoflurane in 40 participants. Completed in 5 March 2025.

Timeline
5 December 2024
Primary endpoint
5 March 2025
5 March 2025

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date5 December 2024
Primary completion5 March 2025
Estimated completion5 March 2025
Sites1 location across China

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 3 to 10, any sex, with Sevoflurane or Cardiac Output. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac output (CO) is measured using Mostcare. Mean systemic filling pressure (MSFP) and vascular resistances are calculated using venous return curves constructed by measuring steady-state arterial and venous pressures and cardiac output (CO) during inspiratory hold manoeuvres at increasing plateau pressures. Measurements are performed at three incremental levels of targeted sevoflurane concentrations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sevoflurane

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06707077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing